iRhythm Technologies (IRTC) Competitors $86.92 -1.88 (-2.12%) (As of 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends IRTC vs. SNN, PEN, GKOS, BLCO, STVN, INSP, PRCT, NVCR, NVST, and NARIShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Stevanato Group (STVN), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), NovoCure (NVCR), Envista (NVST), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Smith & Nephew Penumbra Glaukos Bausch + Lomb Stevanato Group Inspire Medical Systems PROCEPT BioRobotics NovoCure Envista Inari Medical iRhythm Technologies (NASDAQ:IRTC) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends. Does the MarketBeat Community prefer IRTC or SNN? Smith & Nephew received 43 more outperform votes than iRhythm Technologies when rated by MarketBeat users. However, 66.18% of users gave iRhythm Technologies an outperform vote while only 54.43% of users gave Smith & Nephew an outperform vote. CompanyUnderperformOutperformiRhythm TechnologiesOutperform Votes40566.18% Underperform Votes20733.82% Smith & NephewOutperform Votes44854.43% Underperform Votes37545.57% Do analysts rate IRTC or SNN? iRhythm Technologies presently has a consensus price target of $109.27, suggesting a potential upside of 24.39%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Smith & Nephew.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.82Smith & Nephew 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more volatility & risk, IRTC or SNN? iRhythm Technologies has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Do insiders and institutionals hold more shares of IRTC or SNN? 25.6% of Smith & Nephew shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is IRTC or SNN more profitable? Smith & Nephew has a net margin of 0.00% compared to iRhythm Technologies' net margin of -26.90%. Smith & Nephew's return on equity of 0.00% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-26.90% -120.86% -17.96% Smith & Nephew N/A N/A N/A Which has higher valuation & earnings, IRTC or SNN? Smith & Nephew has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$492.68M5.58-$123.41M-$4.86-18.08Smith & Nephew$5.64B1.90$263M$1.9612.54 Does the media refer more to IRTC or SNN? In the previous week, Smith & Nephew had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 1 mentions for Smith & Nephew and 0 mentions for iRhythm Technologies. Smith & Nephew's average media sentiment score of 0.84 beat iRhythm Technologies' score of 0.00 indicating that Smith & Nephew is being referred to more favorably in the news media. Company Overall Sentiment iRhythm Technologies Neutral Smith & Nephew Positive SummarySmith & Nephew beats iRhythm Technologies on 12 of the 18 factors compared between the two stocks. Ad Insiders ExposedNo one’s talking about these Trump tradesAs you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.75B$4.32B$5.17B$9.03BDividend YieldN/A41.46%4.96%4.20%P/E Ratio-18.0825.0987.1417.05Price / Sales5.5851.101,125.75118.75Price / CashN/A43.3543.2737.84Price / Book12.827.024.824.94Net Income-$123.41M$13.64M$120.07M$225.13M7 Day Performance-0.91%1.82%1.02%3.71%1 Month Performance1.02%-2.74%16.06%2.47%1 Year Performance-17.93%36.79%28.43%17.10% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies2.6022 of 5 stars$86.92-2.1%$109.27+25.7%-17.0%$2.72B$492.68M-17.882,000SNNSmith & Nephew3.2638 of 5 stars$24.55-0.4%N/A-9.1%$10.73B$5.64B12.5318,452PENPenumbra4.2141 of 5 stars$240.02-1.0%$258.00+7.5%-4.7%$9.21B$1.16B279.094,200GKOSGlaukos3.8965 of 5 stars$148.83-1.4%$145.92-2.0%+90.2%$8.21B$360.35M-49.28780BLCOBausch + Lomb2.5216 of 5 stars$17.88-0.7%$20.58+15.1%+5.3%$6.30B$4.68B-17.0313,300Positive NewsSTVNStevanato Group2.8678 of 5 stars€20.95+1.9%N/A-20.8%$6.19B$1.09B44.575,635Positive NewsINSPInspire Medical Systems4.6079 of 5 stars$185.28-1.3%$233.58+26.1%-7.3%$5.55B$755.59M173.161,011Short Interest ↑PRCTPROCEPT BioRobotics1.8516 of 5 stars$80.85-0.4%$97.86+21.0%+95.7%$4.22B$199.84M-41.46626NVCRNovoCure3.2541 of 5 stars$30.59-0.7%$32.67+6.8%+105.6%$3.31B$577.74M-21.851,453NVSTEnvista3.4346 of 5 stars$18.62-0.4%$20.65+10.9%-20.0%$3.20B$2.50B-2.4012,800NARIInari Medical2.3768 of 5 stars$52.89-4.6%$61.80+16.8%-18.4%$3.10B$574.50M-39.181,300Short Interest ↑ Related Companies and Tools Related Companies Smith & Nephew Alternatives Penumbra Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Stevanato Group Alternatives Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives NovoCure Alternatives Envista Alternatives Inari Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRTC) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
